Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells
•Active immunotherapy is promising for the development of potent cancer therapeutics.•Various types of artificial antigen-presenting cells (aAPCs) may be used as ‘off-the-shelf’ products to induce antigen-specific T cell activation both ex vivo and in vivo.•Size, shape, cytokine delivery mechanism,...
| Main Authors: | , , , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Elsevier Science Publishers
2014
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4154451/ |